|
Important
Links
USP’s
Anti-Counterfeiting Measures and USP Standards policy:
http://www.usp.org/USPNF/notices/antiCountMeasuresStandards.html
For
additional information, please review the USP Website:
http://www.usp.org/USPNF/notices/postponementGeneralChapter1.html
The
USP
welcomes and encourages any comments on potential,
proposed or official standards. Please respond to
the USP to communicate your views on how the printing
restrictions could be detrimental to the safe and intended
use of your drug products.
Desmond
G. Hunt, M.S., Ph.D.
Department of Standards Development
U. S. Pharmacopeia
Phone: 301-816-8341
Fax: 301-816-8373
Email: dgh@usp.org
|